RG
R Scott Greer

R Scott Greer insider trades: Nektar Therapeutics (NKTR) stock buys and sales

Nektar Therapeutics Last trade Jul 9, 2020 68 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
8
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where R reports to the SEC

and 2 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 9, 2020NKTR↓ Sell$375K
Sep 4, 2018NKTR↓ Sell$674K
Jun 6, 2018NKTR↓ Sell$603K
May 7, 2018SIEN↑ Buy$150K
Apr 6, 2018NKTR↓ Sell$2.8M
Oct 24, 2016NKTR↑ Buy$203K
Nov 11, 2015VSAR↑ Buy$102K
Jan 27, 2015VSAR↑ Buy$95K
Jul 16, 2014ASPX↑ Buy$100K
Jul 6, 2005RNAI↑ Buy$60K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NKTR insiders

Open-market trades in the last 12 months

About R Scott Greer's insider trades

R Scott Greer is an insider at Nektar Therapeutics (NKTR). Since Jul 6, 2005, R has reported 6 open-market purchases worth $709K and 4 sales worth $4.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (45 filings), option exercises (14 filings), shares returned to the company (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NKTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.